Qi Zhang Tatarata
10PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 18, 2024
BCL-2 inhibition in acute myeloid leukemia: resistance and combinations.Qi Zhang Tatarata, Zhe Wang, Marina Konopleva
|Nov 30, 2023
Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL.Ze Tian, Chunhua Shi, Guojun Yang
|Aug 26, 2023
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL.Ze Tian, Chunhua Shi, Guojun Yang
|Apr 21, 2023
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.Yannan Jia, Weiguo Zhang, Mahesh Basyal
|Feb 14, 2023
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia.Seemana Bhattacharya, Sujan Piya, Huaxian Ma
|Jan 19, 2023
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials.Timothy A Yap, Naval Daver, Mikhila Mahendra
Pageof 2
Frequent Collaborators
4 joint publications
Michael Andreeff
4 joint publications
Marina Konopleva
4 joint publications
Natalia Baran
3 joint publications
Hagop M Kantarjian
2 joint publications
Anthony Letai
2 joint publications
Jeffrey J Molldrem
2 joint publications
Ze Tian
2 joint publications
Jill Wardell Olson
2 joint publications
Venkata L Battula
2 joint publications
Jeremy A Ryan
